The regulation of intracellular ascorbic acid (AsA) levels may be under the control of an AsAspecific membrane transporter. The present study investigates AsA uptake and expression of Nadependent vitamin C transporter (SVCT) mRNA in the mouse osteoblastic cell line, MC3T3-E1. Among eight compounds tested, dexamethasone (Dex) all-trans retinoic acid, transforming growth factor b, prostaglandin E 2 and transferrin significantly ðP , 0 : 01; P , 0 : 01; P , 0 : 05 and P , 0 : 01 respectively) stimulated the update of AsA into MC3T3-E1 cells. Among these five, Dex was the most active, inducing mSVCT2 mRNA and the uptake of AsA in a time-and concentration-dependant manner. Dex did not induce mSVCT1 mRNA. These results suggest that the Dex-induced stimulation of AsA incorporation into osteoblastic cells is mediated by the induction of mSVCT2. Since Dex reduced alkaline phosphatase activity in MC3T3-E1 cells in our culture conditions, Dex-induced stimulation of AsA incorporation might not be the result of differentiation. Hormone-regulated changes of SVCT expression may have an important role in cell functions. Ascorbic acid (AsA) is an essential nutrient that has various functions including an essential role in the prolyl and lysyl hydroxylation necessary for the maturation of collagen peptide. It is therefore important in bone formation (Chen & Raisz, 1975) and in the in vitro differentiation of mesenchymal cells including osteoblasts (Franceschi et al. 1994). To be used for these actions, AsA must traverse the cell membrane from the extracellular space. The incorporation of l-[ 14 C]AsA is saturable and Na + -dependant in various types of cells and tissues (Rumsey & Levine, 1998; Fujita et al. 2000). Tsukaguchi et al. (1999) recently cloned two transporters for AsA, called Na-dependant vitamin C transporter (SVCT) 1 and 2, from rat cDNA libraries. However, the relationship between bone formation and SVCT and the significance of SVCT for hormone-regulated change in AsA incorporation remains unknown.
Ascorbic acid (AsA) is an essential nutrient that has various functions including an essential role in the prolyl and lysyl hydroxylation necessary for the maturation of collagen peptide. It is therefore important in bone formation (Chen & Raisz, 1975) and in the in vitro differentiation of mesenchymal cells including osteoblasts (Franceschi et al. 1994) . To be used for these actions, AsA must traverse the cell membrane from the extracellular space. The incorporation of l-[ 14 C] AsA is saturable and Na + -dependant in various types of cells and tissues (Rumsey & Levine, 1998; Fujita et al. 2000) . Tsukaguchi et al. (1999) recently cloned two transporters for AsA, called Na-dependant vitamin C transporter (SVCT) 1 and 2, from rat cDNA libraries. However, the relationship between bone formation and SVCT and the significance of SVCT for hormone-regulated change in AsA incorporation remains unknown.
The murine cell line clone MC3T3-E1 maintains osteoblastic characteristics (Kodama et al. 1981; Quarles et al. 1992; Franceschi et al. 1994) . We used cultured MC3T3-E1 cells as an in vitro model of osteoblasts. Dexamethasone (Dex) stimulates not only osteoblast differentiation (Bellow et al. 1987; Boden et al. 1996) but also Na + -dependant l-[ 14 C]AsA uptake (Pandipati et al. 1998) . However, the relationship between the enhanced uptake and the expression of SVCT had not been investigated. In the present study, we cloned two types of mouse SVCT cDNA and investigated the expression of the SVCT in osteoblastic cells. The data showed that the enhanced transport of AsA by Dex in osteoblastic cells is controlled by SVCT2 expression.
Materials and methods

Cells and cell culture
MC3T3-E cells were originally established by Kodama et al. (1981) from mouse calvaria. MC3T3-E1 (a clone of MC3T3-E) cells were obtained from Dr T. Miyahara (Toyama Medical and Pharmaceutical University, Toyama, Japan) and cultured in a-modification of Eagle's medium with 100 ml fetal calf serum/l in a humidified atmosphere of CO 2 -air (5:95, v/v) . For uptake assay, cells were seeded on twenty-four-well culture plates at a density of 1 : 0 Â 10 5 cells/500 ml per well and incubated for 24 h. For RNA preparation, cells were plated on 10 cm culture dishes at a density of 2 : 5 Â 10 6 cells/10 ml and incubated for 24 h. Cells were then exposed to various compounds under controlled conditions in serum-free medium. Uptake assays or RNA preparation proceeded after exposure for various periods.
Ascorbic acid incorporation
MC3T3-E1 cells in twenty-four-well culture plates were rinsed with incubation medium composed of 10 mm-2-(4-(2-hydroxyethyl)-1-piperazinyl)ethanesulfonic acid, 137 mmNaCl, 5 : 4 mm-KCl, 0 : 3 mm-Na 2 HPO 3 , 0 : 4 mm-KH 2 PO 4 , 0 : 4 mm-MgSO 4 , 1 : 3 mm-CaCl 2 , 0 : 5 mm-MgCl 2 and 0 : 5 mmthiourea, pH 7 : 4. Cells were then incubated with the same medium containing various concentrations of l-[
14 C]AsA (0 : 295 MBq/mmol; NEN-DuPont, Boston, MA; USA) at 378C for 60 min in air. The incorporation radioactivity was measured using a liquid scintillation counter. Non-specific incorporation was determined using an excess amount of cold AsA at a concentration of 10 mm. Specific incorporation was calculated as total incorporation minus nonspecific incorporation. Values are normalised with protein contents and are expressed as relative units unless otherwise indicated.
cDNA cloning
A search of the sequence database revealed that mouse yokesac permease-like molecule-3 (mYspl3; GenBank ac. no. AF058320) cDNA (Faaland et al. 1998) has high homology to rSVCT1 (93 %). On the basis of this sequence similarity, we assumed that mYspl3 is the mouse counterpart of rSVCT1. On the other hand, a mouse cDNA similar to rSVCT2 was not found in the database. Type 2 SVCT have been cloned only from rats and human subjects (Rajan et al. 1999; Tsukaguchi et al. 1999; Daruwala et al. 1999) . We designed polymerase chain reaction primers based on the 5 0 -and 3 0 -non-coding region conserved in rSVCT2 and hSVCT2 cDNA. The cDNA for mYspl3/mSVCT1 and mSVCT2 cDNA were generated by polymerase chain reaction from a mouse kidney and from a mouse brain cDNA pool respectively. The primers were ATGAAAACTCCGG-AGGACCCC and TCAGACCTTGGTACACACAGACCC for mYspl3/mSVCT1, ATGATGGGTGTCGGCAAGAA and ACAGATGCATGCCGTACT-GT for mSVCT2. SVCT cDNA fragments generated by polymerase chain reaction were subcloned into pBluescript II and sequenced. The sequence of the mYspl3 cDNA fragment matched that from the database. The sequence from the predicted mSVCT2 cDNA fragment had high homology to rSVCT2 (96 %).
Northern blots
Cellular RNA was isolated, and 6 mg total RNA was fractionated on a 1 % formaldehyde -3-(N-morpholino)propanesulfonic acid agarose gel. RNA in the gel was capillary transferred to Hybond-N membranes (Amersham Pharmacia, Amersham, Bucks., UK) then immobilised by u.v. crosslinking. mYspl3/mSVCT1 and mSVCT2 cDNA fragments were labelled with [a-32 P]dCTP and hybridised with the blot. The mRNA signals were detected and analysed using a BAS1500 Mac radio imaging system (FUJI FILM, Tokyo, Japan). All membranes were reprobed with a 32 P-labelled DNA probe for mouse 18S rRNA as an internal control.
Statistical analysis
The data were analysed by ANOVA and the Dunnett multiple comparisons test.
Results
The uptake of AsA into MC3T3-E1 cells was originally reported by Franceschi et al. (1994) . We confirmed AsAspecific and Na 5 cells per/h, respectively. Na dependence was also confirmed in our experimental conditions. Little has been published regarding the stimulation of AsA transport by endogenous factors in osteoblastic cells (Wilson & Dixon, 1995; Pandipati et al. 1998) . MC3T3-E1 cells were incubated for 24 h with eight compounds indicated in Fig. 1 , all of which are supposed to promote osteoblast differentiation and/or proliferation. The maximum stimulative concentrations were based on the results of differentiation-and proliferation-inducing experiments (Kumegawa et al. 1983; Tsunoi et al. 1984; Hakeda et al. 1985; Katagiri et al. 1990; Amarnani et al. 1993; Kanatani et al. 1993; Kaji et al. 1995; Kasperk et al. 1995) . The uptake of l-[ 14 C]AsA was significantly increased by Dex (10 27 m), all-trans retinoic acid (10 27 m), transforming growth factor b (10 ng/ml), transferrin (10 27 m) and prostaglandin E 2 (10 27 m) (Fig. 1) . The greatest response was elicited by Dex. In addition to Dex and transforming growth factor b (Wilson & Dixon, 1995; Pandipati et al. 1998) , we found three more factors that stimulate AsA uptake in osteoblastic cells.
To examine whether the stimulative effect of Dex on AsA uptake is mediated by the induction of mYspl3/mSVCT1 and/or mSVCT2, we examined mSVCT mRNA expression in MC3T3-E1 cells. MC3T3-E1 cells cultured with Dex for 24 h showed a dose-dependent increase of mSVCT2 mRNA (Fig. 2(A) ). On the other hand, mYspl3/mSVCT1 mRNA was not detected in MC3T3-E1 cells. The Dex-induced induction of mSVCT2 mRNA was consistent with the results of AsA-uptake into 48 h-treated cells in the same concentration range. We also examined the time course of the upregulated mSVCT2 mRNA expression and AsA uptake induced by Dex in MC3T3-E1 cells. The mSVCT2 mRNA level was upregulated in MC3T3-E1 cell incubated for 4-8 h with 10 26 m-Dex and the expression of mSVCT2 mRNA was time-dependant ( Fig. 2(B) ). The AsA uptake also increased a few hours after the induction of mSVCT2 mRNA. We did not detect mYspl3/mSVCT1 mRNA in the present study. Alkaline phosphatase activity, a differentiation marker of osteoblasts, in PEG-p-isooctylphenyl ethyl (NP-40) extract was determined in the Dex-treated cells. Dex (0 : 1 mm) reduced alkaline phosphatase activity timedependently (75 % and 58 % of control at 24 and 48 h, respectively).
Discussion
Two cDNA encoding the transporters rSVCT1 and rSVCT2, have been isolated from a rat kidney cDNA library (Tsukaguchi et al. 1999) . These transporters possess high affinity and specificity to AsA and are driven by a Na + gradient. The cDNA sequences of hSVCT1 and hSVCT2 were later identified as the human homologues of rSVCT1 and rSVCT2 respectively (Rajan et al. 1999; Wang et al. 2000) . We isolated cDNA for the mouse homologues of rSVCT, mYspl3/mSVCT1 and mSVCT2. The sequences of mSVCT showed high similarity to the rat and human clones. Tsukaguchi et al. (1999) have shown that not SVCT1 but SVCT2 is predominantly expressed in osteoblasts. Our result from control culture supports their observation (Fig. 2) . The cells in which Dex enhanced the uptake of AsA did not appear to express mSVCT1 mRNA. These findings show that the transport of AsA in MC3T3-E1 cells is driven by the Na + gradient-dependant AsA-specific transporter, SVCT2. The apparent K m value of rSVCT2 for AsA is 30 mm (Tsukaguchi et al. 1999 ) and the estimated value of murine MC3T3-E1 cells was 50 mm in the present study. The reported concentration of AsA in plasma and extracellular fluid is about 50 mm (Hornig, 1975) . Therefore, SVCT2 would act as a transporter in vivo, and the expressional change of SVCT2 would influence the cellular concentration of AsA in vivo.
Osteoblastic cells can synthesise extracellular matrix and cause it to differentiate (Gerstenfeld et al. 1987) . Ascorbic acid relates not only to the formation of collagen but also to the differentiation of osteoblasts (Franceschi et al. 1994) . The activity of the osteoblast-specific transcription factor, which is essential for osteoblast function, is stimulated by AsA (Ducy et al. 1997) . Therefore, changes in the AsA transport should have profound effects on osteoblast function.
Several factors such as hormones and growth factors also affect osteoblastic cell function. For example, Dex or transforming growth factor b can stimulate not only the synthesis of extracellular matrix but also Na
AsA uptake (Wilson & Dixon, 1995; Pandipati et al. 1998) . However, the relationship between these actions and the expression of AsA transporters was unknown. The present study showed that Dex-induced stimulation of AsA uptake is due to the enhanced expression of mSVCT2. Other than Dex and transforming growth factor b, we found that all-trans retinoic acid, prostaglandin E 2 and transferrin also induce the AsA-transport activity of osteoblastic cell (Fig. 1) . It is important to define the SVCT-inducing activity of these AsA-transport inducers.
Glucocorticoid at high concentrations has potent longterm antiproliferative effects on mesenchymal cells, including bone cells (Kasperk et al. 1995; Ishida et al. 1996) . In the present study, 1 mm Dex inhibited about 30 % of the protein content compared with control in vitro (results not shown). At low concentrations, short-term experiments have shown that glucocorticoids stimulate osteoblast proliferation (Kasperk et al. 1995) . Thus, the effects of glucocorticoid may be related not only to dose and treatment duration but also to the degree of cellular differentiation. At physiological concentrations, glucocorticoid provides a basal stimulus for differentiation, ensuring not only a continuous stream of mesenchymal stem cells maturing into proliferating osteoblastic precursor cells, but also their differentiation into osteoblasts. Although a promoter sequence of mSVCT2 has not yet been identified, we speculated that glucocorticoid-responsive element is located in the promoter region of the mSVCT2 gene. We also speculate that another mechanism is responsible for the Dex-induced expression of mSVCT2. Levels of the differentiation-related transcription factor, osteoblasticspecific transcription factor, are increased by Dex (Chang et al. 1998 ) and this factor may regulate mSVCT2 mRNA expression.
In our experimental conditions, alkaline phosphatase activity in MC3T3-E1 cells was reduced by Dex. Therefore, Dex-induced expression of SVCT2 is not a result of osteoblastic differentiation. The role of SVCT in osteoblast differentiation and the molecular mechanism of the glucocorticoid-induced expression of SVCT2 remain to be elucidated. AsA must be involved in the growth and function of various cells, rather than only those of osteoblastic lineage. Regulation of the expression of the SVCT in other cells should also be investigated.
